Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 9/20 | 0.33 |
| ▸ | F2 | P00734 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | APAF1 | O14727 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GRK2 | P25098 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | Q9HBH1 | 1/20 | 0.30 | |
| ▸ | F2RL1 | P55085 | 1/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30890606 | 0.90 | F2 (0.33) | CNR2F2RECQLTDP1OPRM1 | |
| SCHEMBL30890405 | 0.88 | CNR2 (0.33) | CNR2F2PDF | |
| SCHEMBL27244932 | 0.85 | NPC1 (0.37) | NPC1CNR2KDM4E | |
| SCHEMBL27244908 | 0.85 | NPC1 (0.37) | NPC1CNR2KDM4E | |
| SCHEMBL27245075 | 0.83 | NPC1 (0.34) | NPC1CNR2 | |
| SCHEMBL27245064 | 0.83 | NPC1 (0.34) | NPC1CNR2 | |
| SCHEMBL30992231 | 0.81 | NPC1 (0.33) | NPC1CNR2KDM4E | |
| Hydrochloric Acid SCHEMBL27244640 | 0.80 | AKR1B1 (0.33) | F2KDM4E | |
| Hydrochloric Acid SCHEMBL27244661 | 0.80 | AKR1B1 (0.33) | F2KDM4E | |
| SCHEMBL30890739 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612156-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |